MALIGNITETER in English translation

• malignancies
• malignancy

Examples of using Maligniteter in Danish and their translations into English

Oplysninger om tilfælde af maligniteter, der er blevet indberettet efter markedsføringen.
A statement reflecting the cases of malignancies reported in the post-marketing.

Højere forekomst af maligniteter er blevet forbundet med behandlingsformer, som påvirker immunsystemet.
A higher rate of malignancies has been associated with therapies affecting the immune system.

TPO- receptorstimulatorer kan i teorien stimulere progression af eksisterende hæmatopoietiske maligniteter eller MDS.
For TPO receptor stimulators there is a theoretical concern that they may stimulate the progression of existing haematopoietic malignancies or MDS.

Non- melanom hudcancer indtraf hos 3, 6% af patienterne og andre maligniteter hos 1.
Non-melanoma skin carcinomas occurred in 3.6% of patients; other types of malignancy occurred in 1.1% of patients.

Strålingsdosen fra den terapeutiske udsættelse kan resultere i sekundære maligniteter og i udvikling af arvelige defekter.
The radiation dose resulting from therapeutic exposure may result in secondary malignancies and in development of hereditary defects.

Bivirkninger under behandlingen med erytropoietin er især observeres hos patienter med kronisk nyresvigt eller underliggende maligniteter.
Undesirable effects during treatment with erythropoietin are observed predominantly in patients with chronic renal failure or underlying malignancies.

Nonmelanom hudcancer indtraf hos 3, 6% af patienterne og andre maligniteter hos 1.
Non-melanoma skin carcinomas occurred in 3.6% of patients; other types of malignancy occurred in 1.1% of patients.

Undersøgelsen omfattede 705 anæmiske patienter med ikke- myeloide maligniteter, som modtog kemoterapi med flere cyklusser.
This study was conducted in 705 anaemic patients with non-myeloid malignancies receiving multi-cycle chemotherapy.

Hyppigheden af ikke- kutane maligniteter af forskellig type var signifikant højere hos patienter behandlet med Enbrel end i kontrolgruppen.
The incidence of non-cutaneous malignancies of various types was significantly higher in patients treated with Enbrel than in the control group.

Maligniteter og lymfoproliferative sygdomme Det vides endnu ikke, om Raptiva kan øge risikoen for lymfoproliferative sygdomme eller andre maligniteter hos psoriasis- patienter.
Malignancies and lymphoproliferative disorders It is not yet known whether or not Raptiva can increase the risk of lymphoproliferative disorders or other malignancies in psoriasis patients.

Toksicitet på langt sigt hos patienter, der ændrer sig udviklingsmæssigt.• Eventuel forekomst af maligniteter samt andre risici.
Long-term toxicity in patients undergoing developmental changes• Possible occurrence of malignancies as well as other risks.

Sekundære maligniteter Ligesom andre nukleoside analoger,
Secondary malignancies Like other nucleoside analogues,

progressionsfri overlevelse og sekundære maligniteter.
progression free survival and secondary malignancies.

kaldes metastatisk maligniteter til leveren.
are called metastatic malignancies to the liver.

også blevet rapporteret ved behandling af andre maligniteter end APL med TRISENOX.
has also been reported for the treatment of malignancies other than APL with TRISENOX.

kan påvirke forsvaret mod infektioner og maligniteter samt påvirke vaccinationsrespons.
may affect host defences against infections and malignancies, and affect vaccination responses.

Efter markedsføring har et meget lille antal personer, som har brugt Protopic salve, haft maligniteter f. eks. hud eller lymfom.
Since commercial availability a very small number of people who have used Protopic ointment have had malignancies for example, skin or lymphoma.

Sikkerhedsdata er baseret på 3 randomiserede, placebo kontrollerede kliniske forsøg og et farmakokinetisk forsøg omfattede 650 patienter med hæmatologiske maligniteter.
Safety data are based upon 650 patients with haematological malignancies enrolled in 3 randomised, placebo-controlled clinical studies and a pharmacokinetic study.

Sekundære maligniteter Myelodysplasi/ akut myeloid leukæmi(AML) er blevet rapporteret
Secondary malignancies Myelodysplasia/ acute myeloid leukaemia(AML)

Der er i dobbeltblinde og åbne kliniske forsøg rapporteret maligniteter hos 66 ud af 2. 688 abataceptbehandlede patienter gennem 4. 764 patientår.
In double-blind and open-label clinical trials, malignancies were reported in 66 of 2,688 abatacept-treated patients during 4,764 patient-years.